CH423096A - Procédé de préparation d'un médicament bactério-thérapeutique - Google Patents

Procédé de préparation d'un médicament bactério-thérapeutique

Info

Publication number
CH423096A
CH423096A CH844263A CH844263A CH423096A CH 423096 A CH423096 A CH 423096A CH 844263 A CH844263 A CH 844263A CH 844263 A CH844263 A CH 844263A CH 423096 A CH423096 A CH 423096A
Authority
CH
Switzerland
Prior art keywords
culture
escherichia coli
lactobacillus acidophilus
milk
mucin
Prior art date
Application number
CH844263A
Other languages
English (en)
French (fr)
Original Assignee
Eurorga Societe Anonyme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR904533A external-priority patent/FR2427M/fr
Application filed by Eurorga Societe Anonyme filed Critical Eurorga Societe Anonyme
Publication of CH423096A publication Critical patent/CH423096A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1735—Mucins, e.g. human intestinal mucin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CH844263A 1962-07-19 1963-07-05 Procédé de préparation d'un médicament bactério-thérapeutique CH423096A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR904533A FR2427M (fr) 1962-07-19 1962-07-19 Médicament bactériothérapique, en particulier pour le traitement d'affections gastro-intestinales.
FR939081 1963-06-24

Publications (1)

Publication Number Publication Date
CH423096A true CH423096A (fr) 1966-10-31

Family

ID=26196723

Family Applications (1)

Application Number Title Priority Date Filing Date
CH844263A CH423096A (fr) 1962-07-19 1963-07-05 Procédé de préparation d'un médicament bactério-thérapeutique

Country Status (4)

Country Link
CH (1) CH423096A (da)
DK (1) DK108015C (da)
GB (1) GB1015956A (da)
LU (1) LU44002A1 (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2352058A1 (fr) * 1976-05-21 1977-12-16 Seiken Kai Foundation Nouveau desodorisant et son procede de preparation et de conservation

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI59925C (fi) * 1980-01-11 1981-11-10 Esko Viljo Nurmi Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
WO2023104887A1 (en) * 2021-12-09 2023-06-15 Société des Produits Nestlé S.A. Lactobacillus acidophilus to increase agmatine production by microbiota

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2352058A1 (fr) * 1976-05-21 1977-12-16 Seiken Kai Foundation Nouveau desodorisant et son procede de preparation et de conservation

Also Published As

Publication number Publication date
DK108015C (da) 1967-07-31
GB1015956A (en) 1966-01-05
LU44002A1 (da) 1963-09-03

Similar Documents

Publication Publication Date Title
US3320130A (en) Medicament for colitis, gastroenteritis and enterocolitis
Singh et al. Probiotics: A review
CN100360658C (zh) 肠道微生态制剂及其制备方法
US8192733B2 (en) Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
JP5517215B2 (ja) 発酵及び培養方法、植物発酵エキス、植物発酵エキス末並びに該植物発酵エキス配合物
CN1099289C (zh) 改善肠道生态平衡的微生物制剂及其工艺
KR20020019059A (ko) 박테리아 균주, 식물 가공 추출물, 및 인간 및 수의학적사용을 위한 생균활성 조성물
KR19990035918A (ko) 스트렙토코커스 써머필러스와 비피도박테리움 롱검을 포함하는 경장(經腸)용 식이 조성물
FR2853908A1 (fr) Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant
CN109315769A (zh) 一种用于改善人体肠内环境的组合物及其制备方法
CN115120646A (zh) 一种平衡肠道菌群的益生菌组合物及其制备方法和应用
US20130022577A1 (en) Probiotic compositions useful for treatment of bipolar disorder
JP4193269B2 (ja) 新規な生体浄化活性型乳酸菌製剤
JP2005013211A (ja) 乳酸菌含有食品組成物
CN116509907A (zh) 一种对口腔疾病有改善的后生元及其应用
CH423096A (fr) Procédé de préparation d'un médicament bactério-thérapeutique
JP5502449B2 (ja) 腸内フローラバランス改善剤及びその製造方法
RU2252770C2 (ru) Лечебно-профилактическое средство "бионорм", способ его получения и способ его применения
JPH10108672A (ja) ビフィズス因子の活性増強・安定化剤
JP2000502247A (ja) 腸管内細菌相の生物学的平衡を改善するための吸収可能な食餌組成物
RU2264451C2 (ru) Биопрепарат "бифистим от 3 месяцев до 3 лет" для профилактики и лечения дисбактериозов и инфекционнных болезней желудочно-кишечного тракта у детей в возрасте от 3 месяцев до 3 лет, биологически активная добавка к пище "бифистим от 3 месяцев до 3 лет" для профилактики дисбактериозов и восстановления микрофлоры желудочно-кишечного тракта после антибиотикотерапии и других неблагоприятных воздействий у детей в возрасте от 3 месяцев до 3 лет и консорциум бифидобактерий для коррекции микрофлоры желудочно-кишечного тракта у детей в возрасте от 3 месяцев до 3 лет
HU190782B (en) Process for producing pharmaceutical compositions for profilacting and treating negative changes of hygienics on epithelium
JPH0338593A (ja) 新規オリゴ糖とその製造法及び利用
RU2221582C2 (ru) Средство для лечения дисбактериоза и способ его получения
Schmitt et al. Effect of xylitol on the growth of Lactobacillus acidophilus for food and pharmaceutical applications Efeito do xilitol no crescimento do Lactobacillus acidophilus em alimentos e aplicações farmacêuticas